Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiu-Wen Huang

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
European Journal of Pharmacology|March 29, 2026
Nstpbp5185, a novel benzimidazole derivative, suppresses PDGF signaling and reduces neointimal hyperplasia following vascular injuryMing-Jen Hsu, Shih-Hsin Hsiao, Jin-Cherng Lien, et al.
Plos One|August 29, 2015
Protein Phosphatase 2A in Lipopolysaccharide-Induced Cyclooxygenase-2 Expression in Murine Lymphatic Endothelial CellsYu-Fan Chuang, Mei-Chieh Chen, Shiu-Wen Huang, et al.
British Journal of Pharmacology|June 25, 2017
WMJ-8-B, a novel hydroxamate derivative, induces MDA-MB-231 breast cancer cell death via the SHP-1-STAT3-survivin cascadeYu-Fan Chuang, Shiu-Wen Huang, Ya-Fen Hsu, et al.
Analytica Chimica Acta|January 12, 2025
A sensitive post-column derivatization approach for enhancing hydroxyl metabolites detectionYen-Chu Lin, Shiu-Wen Huang, San-Yuan Wang, et al.
International Journal of Molecular Sciences|April 13, 2023
Src-FAK Signaling Mediates Interleukin 6-Induced HCT116 Colorectal Cancer Epithelial-Mesenchymal TransitionYu-Han Huang, Han-Kun Chen, Ya-Fen Hsu, et al.
Stem Cell Research & Therapy|November 19, 2025
Harnessing engineered mesenchymal stem cell-derived extracellular vesicles for innovative cancer treatmentsWei-Lun Hwang, Shiu-Wen Huang, An-Ching Hsiao, et al.
Nutrients|May 27, 2023
Effects of Nonnutritive Sweeteners on Body Composition Changes during Pubertal GrowthYu-Hsin Chien, Chia-Yuan Lin, Shih-Yuan Hsu, et al.
Oncotarget|November 22, 2014
WMJ-S-001, a novel aliphatic hydroxamate derivative, exhibits anti-angiogenic activities via Src-homology-2-domain-containing protein tyrosine phosphatase 1Yi-Fang Chang, Ya-Fen Hsu, Pei-Ting Chiu, et al.
British Journal of Pharmacology|August 2, 2019
A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signallingJin-Cherng Lien, Chi-Li Chung, Tur-Fu Huang, et al.
Frontiers in Oncology|November 30, 2019
WMJ-S-001, a Novel Aliphatic Hydroxamate-Based Compound, Suppresses Lymphangiogenesis Through p38mapk-p53-survivin Signaling CascadeShiu-Wen Huang, Hung-Yu Yang, Wei-Jan Huang, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
European Journal of Pharmacology|March 29, 2026
Nstpbp5185, a novel benzimidazole derivative, suppresses PDGF signaling and reduces neointimal hyperplasia following vascular injuryMing-Jen Hsu, Shih-Hsin Hsiao, Jin-Cherng Lien, et al.
Plos One|August 29, 2015
Protein Phosphatase 2A in Lipopolysaccharide-Induced Cyclooxygenase-2 Expression in Murine Lymphatic Endothelial CellsYu-Fan Chuang, Mei-Chieh Chen, Shiu-Wen Huang, et al.
British Journal of Pharmacology|June 25, 2017
WMJ-8-B, a novel hydroxamate derivative, induces MDA-MB-231 breast cancer cell death via the SHP-1-STAT3-survivin cascadeYu-Fan Chuang, Shiu-Wen Huang, Ya-Fen Hsu, et al.
Analytica Chimica Acta|January 12, 2025
A sensitive post-column derivatization approach for enhancing hydroxyl metabolites detectionYen-Chu Lin, Shiu-Wen Huang, San-Yuan Wang, et al.
International Journal of Molecular Sciences|April 13, 2023
Src-FAK Signaling Mediates Interleukin 6-Induced HCT116 Colorectal Cancer Epithelial-Mesenchymal TransitionYu-Han Huang, Han-Kun Chen, Ya-Fen Hsu, et al.
Stem Cell Research & Therapy|November 19, 2025
Harnessing engineered mesenchymal stem cell-derived extracellular vesicles for innovative cancer treatmentsWei-Lun Hwang, Shiu-Wen Huang, An-Ching Hsiao, et al.
Nutrients|May 27, 2023
Effects of Nonnutritive Sweeteners on Body Composition Changes during Pubertal GrowthYu-Hsin Chien, Chia-Yuan Lin, Shih-Yuan Hsu, et al.
Oncotarget|November 22, 2014
WMJ-S-001, a novel aliphatic hydroxamate derivative, exhibits anti-angiogenic activities via Src-homology-2-domain-containing protein tyrosine phosphatase 1Yi-Fang Chang, Ya-Fen Hsu, Pei-Ting Chiu, et al.
British Journal of Pharmacology|August 2, 2019
A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signallingJin-Cherng Lien, Chi-Li Chung, Tur-Fu Huang, et al.
Frontiers in Oncology|November 30, 2019
WMJ-S-001, a Novel Aliphatic Hydroxamate-Based Compound, Suppresses Lymphangiogenesis Through p38mapk-p53-survivin Signaling CascadeShiu-Wen Huang, Hung-Yu Yang, Wei-Jan Huang, et al.
Pageof 3